Cardiometabolic factors’ and cardiovascular risk in young adult cancer survivors: evidence from real-world data - Summary - MDSpire

Cardiometabolic factors’ and cardiovascular risk in young adult cancer survivors: evidence from real-world data

  • By

  • Samah Hayek

  • Jinyi Li

  • Jiahui Dai

  • Joel Milam

  • Luohua Jiang

  • August 12, 2025

  • 0 min

Share

Objective:

To assess the burden of cardiometabolic factors and their associations with cardiovascular disease (CVD) among young adult cancer survivors (aged 19-39 years at diagnosis), while exploring ethnic disparities.

Key Findings:
  • Cardiometabolic factors were more prevalent in cancer survivors compared to non-cancer participants.
  • Significant associations were found between Type 2 diabetes and increased odds of myocardial infarction (OR: 6.99; 95% CI: 3.45–14.19) and congestive heart failure (OR: 12.304; 95% CI: 7.23–20.91).
  • Hypertension was strongly associated with congestive heart failure (OR: 20.48; 95% CI: 11.79–35.57).
  • Racial/ethnic disparities in cardiometabolic factors and CVD risk were observed.
Interpretation:

Cardiometabolic factors independently contribute to elevated CVD risk in young adult cancer survivors, highlighting the urgent need for integrated risk assessment and prevention strategies in survivorship care.

Limitations:
  • Retrospective design may limit causality conclusions.
  • Potential confounding factors not accounted for in the analysis.
  • Data limited to a single healthcare system may affect generalizability and diversity of the sample.
Conclusion:

Young adult cancer survivors face significant cardiometabolic risks that increase their likelihood of developing cardiovascular diseases, highlighting the need for proactive management and early screening.

Original Source(s)

Related Content